International consensus on the use of tau PET imaging agent F-18-flortaucipir in Alzheimer's disease
Por:
Tian, M, Civelek, AC, Carrio, I, Watanabe, Y, Kang, KW, Murakami, K, Garibotto, V, Prior, JO, Barthel, H, Zhou, R, Hou, HF, Dou, XF, Jin, CT, Zuo, CT, Zhang, H
Publicada:
1 feb 2022
Ahead of Print:
1 ene 2022
Resumen:
Purpose Positron emission tomography (PET) with the first and only tau targeting radiotracer of F-18-flortaucipir approved by FDA has been increasingly used in depicting tau pathology deposition and distribution in patients with cognitive impairment. The goal of this international consensus is to help nuclear medicine practitioners procedurally perform F-18-flortaucipir PET imaging. Method A multidisciplinary task group formed by experts from various countries discussed and approved the consensus for F-18-flortaucipir PET imaging in Alzheimer's disease (AD), focusing on clinical scenarios, patient preparation, and administered activities, as well as image acquisition, processing, interpretation, and reporting. Conclusion This international consensus and practice guideline will help to promote the standardized use of F-18-flortaucipir PET in patients with AD. It will become an international standard for this purpose in clinical practice.
Filiaciones:
Tian, M:
Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200235, Peoples R China
Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zhejiang Univ, PET Ctr, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Fudan Univ, Human Phenome Inst, Shanghai 201203, Peoples R China
Civelek, AC:
Johns Hopkins Med, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
Carrio, I:
Autonomous Univ Barcelona, Dept Nucl Med, Hosp St Pau, Barcelona 08025, Spain
Watanabe, Y:
RIKEN, Lab Pathophysiol & Hlth Sci, Ctr Biosyst Dynam Res, Kobe, Hyogo 6500047, Japan
Kang, KW:
Seoul Natl Univ, Dept Nucl Med, Coll Med, Seoul 03080, South Korea
Murakami, K:
Juntendo Univ Hosp, Dept Radiol, Tokyo 1138431, Japan
Garibotto, V:
Univ Geneva, Univ Hosp Geneva, Diagnost Dept, Geneva, Switzerland
Univ Geneva, NIMTLab, Geneva, Switzerland
Prior, JO:
Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland
Barthel, H:
Univ Leipzig, Dept Nucl Med, Med Ctr, Leipzig, Germany
Zhou, R:
Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zhejiang Univ, PET Ctr, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Hou, HF:
Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zhejiang Univ, PET Ctr, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Dou, XF:
Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zhejiang Univ, PET Ctr, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Jin, CT:
Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zhejiang Univ, PET Ctr, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zuo, CT:
Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200235, Peoples R China
Fudan Univ, Huashan Hosp, Natl Ctr Neurol Disorders, Shanghai 200040, Peoples R China
Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai 200040, Peoples R China
Zhang, H:
Zhejiang Univ, Dept Nucl Med, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Zhejiang Univ, PET Ctr, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou 310009, Peoples R China
Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310007, Peoples R China
Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Hangzhou 310007, Peoples R China
Green Published, hybrid
|